{"doi":"10.1093/infdis/jiab283","title":"Virological Characterization of Critically Ill Patients With COVID-19 in the United Kingdom: Interactions of Viral Load, Antibody Status, and B.1.1.7 Infection","abstract":"BACKGROUND: Convalescent plasma containing neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is under investigation for coronavirus disease 2019 (COVID-19) treatment. We report diverse virological characteristics of UK intensive care patients enrolled in the Immunoglobulin Domain of the REMAP-CAP randomized controlled trial that potentially influence treatment outcomes. METHODS: SARS-CoV-2 RNA in nasopharyngeal swabs collected pretreatment was quantified by PCR. Antibody status was determined by spike-protein ELISA. B.1.1.7 was differentiated from other SARS-CoV-2 strains using allele-specific probes or restriction site polymorphism (SfcI) targeting D1118H. RESULTS: Of 1274 subjects, 90% were PCR positive with viral loads 118-1.7 × 1011IU/mL. Median viral loads were 40-fold higher in those IgG seronegative (n = 354; 28%) compared to seropositives (n = 939; 72%). Frequencies of B.1.1.7 increased from <1% in November 2020 to 82% of subjects in January 2021. Seronegative individuals with wild-type SARS-CoV-2 had significantly higher viral loads than seropositives (medians 5.8 × 106 and 2.0 × 105 IU/mL, respectively; P = 2 × 10-15). CONCLUSIONS: High viral loads in seropositive B.1.1.7-infected subjects and resistance to seroconversion indicate less effective clearance by innate and adaptive immune responses. SARS-CoV-2 strain, viral loads, and antibody status define subgroups for analysis of treatment efficacy.","journal":"The Journal of Infectious Diseases","year":2021,"id":175443,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":22,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9447,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":716541,"name":"Dung Nguyen","orcid":"0000-0001-9390-9990","position":1,"is_corresponding":false},{"id":89097,"name":"Marcia B. Goldberg","orcid":"0000-0003-4266-9733","position":2,"is_corresponding":false},{"id":716542,"name":"Jennifer Rynne","orcid":"0000-0002-8945-8434","position":3,"is_corresponding":false},{"id":716543,"name":"A.R. Jennings","orcid":"0000-0002-6954-5717","position":4,"is_corresponding":false},{"id":82721,"name":"Sarah Williams","orcid":"0000-0001-5964-1329","position":5,"is_corresponding":false},{"id":716544,"name":"Farah Al-Beidh","orcid":"0000-0003-4701-463X","position":6,"is_corresponding":false},{"id":395919,"name":"David Bonsall","orcid":"0000-0003-2187-0550","position":7,"is_corresponding":false},{"id":716545,"name":"Amy Evans","orcid":"0000-0002-6664-9342","position":8,"is_corresponding":false},{"id":395920,"name":"Tanya Golubchik","orcid":"0000-0003-2765-9828","position":9,"is_corresponding":false},{"id":3860,"name":"Anthony C. Gordon","orcid":"0000-0002-0419-547X","position":10,"is_corresponding":false},{"id":70569,"name":"Abigail Lamikanra","orcid":"0000-0002-9287-2177","position":11,"is_corresponding":false},{"id":717317,"name":"Pat Tsang","orcid":null,"position":12,"is_corresponding":false},{"id":716546,"name":"Nick Ciccone","orcid":"0000-0002-3612-3198","position":13,"is_corresponding":false},{"id":717318,"name":"Ullrich Leuscher","orcid":null,"position":14,"is_corresponding":false},{"id":717319,"name":"W. K. Slack","orcid":null,"position":15,"is_corresponding":false},{"id":716547,"name":"Emma Laing","orcid":"0000-0002-8309-0990","position":16,"is_corresponding":false},{"id":716548,"name":"Paul Mouncey","orcid":"0000-0002-8510-8517","position":17,"is_corresponding":false},{"id":717320,"name":"Sheba Ziyenge","orcid":null,"position":18,"is_corresponding":false},{"id":554477,"name":"Marta Oliveira","orcid":"0000-0002-3409-5314","position":19,"is_corresponding":false},{"id":554476,"name":"Rutger J. Ploeg","orcid":"0000-0001-7801-665X","position":20,"is_corresponding":false},{"id":74855,"name":"Kathy Rowan","orcid":"0000-0001-8217-5602","position":21,"is_corresponding":false},{"id":237310,"name":"Manu Shankar‐Hari","orcid":"0000-0002-5338-2538","position":22,"is_corresponding":false},{"id":716549,"name":"David Roberts","orcid":"0000-0001-5955-0574","position":23,"is_corresponding":false},{"id":317356,"name":"David Menon","orcid":"0000-0002-3228-9692","position":24,"is_corresponding":false},{"id":70566,"name":"Lise J Estcourt","orcid":"0000-0003-4309-9162","position":25,"is_corresponding":false},{"id":106094,"name":"Peter Simmonds","orcid":"0000-0002-7964-4700","position":26,"is_corresponding":false},{"id":716550,"name":"Heli Harvala","orcid":"0000-0001-9154-4190","position":27,"is_corresponding":false},{"id":717321,"name":"REMAP-CAP Immunoglobulin Domain UK Investigators","orcid":null,"position":28,"is_corresponding":false},{"id":106093,"name":"Jeremy Ratcliff","orcid":"0000-0001-6522-138X","position":0,"is_corresponding":true}],"reference_count":54,"raw_metadata":null,"created_at":"2026-07-18T23:47:15.431199Z","pmid":"34031695","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}